ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Wondering if a credit builder loan will improve loan approvals? We explain how these loans impact credit scores and lender perceptions.
14,314 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
As Greg Abel steers Berkshire Hathaway's non-insurance businesses, Berkshire Hathaway Energy could emerge as a reliab...
A potential power crunch may unlock a rare upside for energy investors. This guide explains why baseload assets like ...
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
Johnson Johnson walking away from a GLP-1 obesity obsession signals a shift to a diversified, potentially more resili...
This article breaks down Alliant Energy's 2025 earnings outlook, capital plan, and dividend strategy. Learn what to w...
A potential $67 billion move between nextera energy and duke energy could redefine how regulated utilities grow, fund...
A year-by-year calculation shows how much capital you need to generate $3,000 a month via dividends, with tradeoffs a...
An escalating scam shows how fake agents manipulate emotions to steal savings. Learn the warning signs, real-world st...
A ransomware attack on Canvas disrupted finals across thousands of schools as the ShinyHunters group claimed responsi...
U.S. households are trimming credit-card balances as total debt hovers near $1.25 trillion, signaling a shift in cons...